北京招聘

·     Works effectively with cross-functional groups to produce high-quality, scientifically accurate documents under strict timelines, and ensures consistency between related documents ·     Develop and manage timelines and communicate with team members to maintain awareness of expectations, milestones, and deliverables ·     Ensure clinical documents adhere to BeiGene standards and regulatory guidelines ·     Ensure that assigned documents undergo a quality check before approval, and that documents are routed correctly during review and approval cycles ·     Ensure the key messages as defined by the team are clearly and adequately represented in the documents; drive the team to reach agreement in case of conflicting opinions. ·     Establish effective cross-functional communication and relationships with counterparts both internally and externally. ·     Participate in departmental or interdepartmental process improvement and training initiatives. ·     Mentor and manage entry-level FTE writers as needed

Qualification

·     Minimum requirement of a master’s degree of life science/pharmacy/ nursing/medical/health related science or equivalent; PhD/PharmD in life sciences preferred ·     More than 1 years of relevant industry experience as a regulatory medical writer ·     Demonstrated ability to communicate and write English clearly, concisely, and effectively ·     Excellent interpersonal skills; a team player ·     Ability to coordinate and manage communications to enable timely reviews from other authors and reviewers and to function as a collaborative team member ·     Ability to understand and interpret clinical and scientific data; ability to present results in an understandable manner ·     Ability to complete high-quality documents according to tight timelines ·     Ability to comply with company and/or industry style guides and templates ·     Strong project management skills ·     Technical expertise in Microsoft Word, Adobe Acrobat, and electronic document management systems

百济神州是一家立足于科学的全球性生物科技公司，专注于开发创新、可负担的药物，旨在为全球患者改善治疗效果，提高药物可及性。目前公司广泛的药物组合包括40多款临床候选药物。公司通过加强自主研发能力和合作，加速推进多元、创新的药物管线开发。我们致力于在2030年前为全球20多亿人全面改善药物可及性。百济神州在全球五大洲打造了一支超过8,000人的团队。